E
Summit Therapeutics Inc. SMMT
$18.80 -$0.49-2.54%
Recommendation
Sell
Prev Close
$20.32
Volume
2,785,772
Avg Vol (90D)
2,302,422
Market Cap
$14.99B
Dividend & Yield
--
52-Week Range
$2.10 - $33.89
P/E (TTM)
--
EPS (TTM)
-$0.3215
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Good
Volatility Index
Weak
Dividend Index
--
Headlines
NEOS Investment Management LLC Makes New $475,000 Investment in Summit Therapeutics Inc. (NASDAQ:SMMT)
4/1/2025 - MarketBeat
Why Biotech Stocks Like Recursion Pharmaceuticals, CRISPR Therapeutics, and Summit Therapeutics Plunged Today
3/31/2025 - Fool.com Headlines
94,760 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Purchased by Artisan Partners Limited Partnership
3/31/2025 - MarketBeat
26,641 Shares in Summit Therapeutics Inc. (NASDAQ:SMMT) Acquired by NEOS Investment Management LLC
3/31/2025 - Ticker Report
Summit Therapeutics (SMMT, $20.32) entered Downtrend as Momentum indicator drops below 0 level on Mar 28, 2025
3/29/2025 - Tickeron - Stocks
Summit Therapeutics (SMMT, $20.32) price exceeded its 50-day Moving Average on March 28, 2025
3/29/2025 - Tickeron - Stocks
Why Is Corcept (CORT) Down 5.3% Since Last Earnings Report?
3/28/2025 - Zacks Investment Research
Summit Therapeutics: Major Upcoming Ivonescimab Data Catalyst May Not Be All It Seems (Rating Downgrade)
3/28/2025 - SeekingAlpha
Summit Therapeutics (SMMT, $20.6) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Summit Therapeutics (SMMT, $20.6) price moved above its 50-day Moving Average on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Summit Therapeutics (NASDAQ:SMMT) Shares Gap Up - Time to Buy?
3/27/2025 - MarketBeat
Summit Therapeutics (NASDAQ:SMMT) Upgraded at Citigroup
3/27/2025 - MarketBeat
Summit Therapeutics (SMMT, $19.89) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2025
3/27/2025 - Tickeron - Technical Analysis
Summit Therapeutics (SMMT) Stock Movement Analysis
3/26/2025 - GuruFocus
Why Summit Therapeutics Stock Slipped Today
3/26/2025 - Fool.com Headlines
Small cap wrap: Nano One Materials, EnWave, Summit Therapeutics...
3/26/2025 - Proactive Investors - UK
Summit Therapeutics upgraded ahead of lung cancer trial data readout
3/26/2025 - Proactive Investors - UK
Summit Therapeutics (SMMT, $20.24) price exceeded its 50-day Moving Average on March 25, 2025
3/26/2025 - Tickeron - Stocks
Summit Therapeutics (SMMT, $20.24) Stochastic Oscillator left the overbought zone on March 25, 2025
3/26/2025 - Tickeron - Stocks
Summit Therapeutics rises as lead asset makes Citi its latest bull
3/26/2025 - SeekingAlpha.com: All News
Summit Therapeutics rises as lead asset makes Citi its latest bull
3/26/2025 - Seeking Alpha - Healthcare
Futures Rise As Tariff Uncertainty Grows Ahead Of "Liberation Day"
3/26/2025 - Zero Hedge
IvyRock Asset Management HK Ltd Invests $2.97 Million in Summit Therapeutics Inc. (NASDAQ:SMMT)
3/26/2025 - MarketBeat
Summit Therapeutics just upgraded at Citi, here's why
3/26/2025 - The Fly
Summit Therapeutics (SMMT, $20.69) price moved above its 50-day Moving Average on March 24, 2025
3/25/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$210.90M
EBIT (TTM)
-$210.99M
Net Income (TTM)
-$221.32M
Balance Sheet
Total Assets (Q)
$435.56M
Total Debt (Q)
$7.22M
Total Liabilities (Q)
$46.81M
Book Value Per Share (Q)
$0.527
Cash Flow
Cash from Operations (TTM)
-$142.11M
Cash from Investing (TTM)
-$205.34M
Cash from Financing (TTM)
$381.23M
Net Change in Cash (TTM)
$33.76M
Filings
Filing Date
Monday, February 24, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Created with Highstock 5.0.1425. Nov9. Dec23. Dec6. Jan20. Jan3. Feb17. Feb3. Mar17. Mar$10.00$20.00$30.00Price as of Mar 28, 2025
Beta
1.96
7-Day Total Return
-3.29%
30-Day Total Return
-12.03%
60-Day Total Return
5.35%
90-Day Total Return
2.68%
Year to Date Total Return
2.45%
1-Year Total Return
372.36%
2-Year Total Return
962.15%
3-Year Total Return
591.18%
5-Year Total Return
693.25%
52-week Low
May 28, 2024 - $2.10
52-week High
Sep 16, 2024 - $33.89
Valuation
Market Cap
$14.99B - Large Cap
Enterprise Value
$14.58B
Price/Sales (TTM)
--
Price/Book (Q)
38.56
Dividends and Shares
Shares Outstanding
737.50M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.summittxinc.com
Phone Number
305-203-2034
Address
601 Brickell Key Drive
Miami, FL 33131
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the... more
NASDAQ 04/01/2025 4:00PM Eastern Quotes delayed
Weiss Ratings